Evidence map›Paper›PMID 36415244›Full record

ArticlePakistan journal of medical sciences

Level of biofilm production by

Salah-Ud-Din, Asad Bashir Awan, Muhammad Mohsin Arshad, Abdul Haque

Abstract read
In one paragraph

Article in Pakistan journal of medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Evolution of copper coupons resistance inPakistan journal of medical sciences · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Salah-Ud-DinSalah-ud-din, BSc. (Hons.), Department of Health Biotechnology, Akhuwat Faisalabad Institute of Research Science and Technology, (FIRST), Faisalabad, Pakistan.
Asad Bashir AwanAsad Bashir Awan, M.Phil, Department of Health Biotechnology, Akhuwat Faisalabad Institute of Research Science and Technology, (FIRST), Faisalabad, Pakistan.
Muhammad Mohsin ArshadMuhammad Mohsin Arshad, M.Phil, Department of Health Biotechnology, Akhuwat Faisalabad Institute of Research Science and Technology, (FIRST), Faisalabad, Pakistan.
Abdul HaqueAbdul Haque, PhD, Department of Health Biotechnology, Akhuwat Faisalabad Institute of Research Science and Technology, (FIRST), Faisalabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: Staphylococcal biofilms cause a wide range of acute and chronic infections, both in hospital and community settings across the world. This study explores biofilm forming propensity among Methods: The study was conducted during July to December 2020. The biofilm forming ability of Results: All the isolates (n=22) produced biofilm; 14 (63.6%) were strong, and 8 (36.4%) moderate biofilm producers. Comparative data were obtained for moderate and strong biofilm producers. Increased biofilm production did not affect azithromycin, clindamycin and mupirocin. However, stronger biofilm production significantly increased resistant isolates in case of augmentin (23.2%), cefoxitin (17.9%), levofloxacin (26.8%), tetracycline (23.2%), vancomycin (14.3%) and trimethoprim (21.4%). Conclusions: Our findings indicate that the ability to produce large amount of biofilm is an important factor, and

Indexed as

Antimicrobial drug resistanceBiofilm productionS. aureus

Identifiers

PMID36415244
PMCPMC9676570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.